SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-000346
Filing Date
2023-01-04
Accepted
2023-01-04 16:59:57
Documents
62
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1257277
2 ex23-1.htm EX-23.1 4403
3 ex31-1.htm EX-31.1 16678
4 ex31-2.htm EX-31.2 17306
5 ex32-1.htm EX-32.1 7090
6 ex32-2.htm EX-32.2 7473
  Complete submission text file 0001493152-23-000346.txt   6025018

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20221031.xsd EX-101.SCH 36350
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anix-20221031_cal.xml EX-101.CAL 46751
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anix-20221031_def.xml EX-101.DEF 172136
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anix-20221031_lab.xml EX-101.LAB 355932
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20221031_pre.xml EX-101.PRE 270279
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1033814
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 23507554
SIC: 2834 Pharmaceutical Preparations